Fig. 7 | Signal Transduction and Targeted Therapy

Fig. 7

From: CRISPR/Cas9 therapeutics: progress and prospects

Fig. 7

Summary chart of FDA-approved CRISPR therapies that can be used in clinical treatments. The text includes the date of FDA approval, the name of the therapy, and the type of applied diseases. DMD Duchenne muscular dystrophy, SCD sickle cell disease, TDT transfusion-dependent β-thalassemia, LCA10 Leber congenital amaurosis type 10, TTR transthyretin. (Figure was created with Biorender.com)

Back to article page